The Modified Human DNA Repair EnzymeO⁶-Methylguanine-DNA Methyltransferase Is a Negative Regulator of Estrogen Receptor-Mediated Transcription upon Alkylation DNA Damage

REFERENCES

• Abott, P., and R. Saffhill. 1979. DNA synthesis with methylated poly (dC · dG) templates; evidence for a competitive nature of miscoding by O6-methylguanine. Biochim. Biophys. Acta 567:51–61.
   Google Scholar
• Ali, R. B., A. K. C. Teo, H. K. Oh, L. S. H. Chuang, T. C. Ayi, and B. F. L. Li. 1998. Implication of localization of human DNA repair enzyme O6-methylguanine-DNA methyltransferase at active transcription sites in transcription-repair coupling of the mutagenic O6-methylguanine lesion. Mol. Cell. Biol. 8:1660–1669.
   Google Scholar
• Ayi, T. C., H. K. Oh, T. K. Y. Lee, and B. F. L. Li. 1994. A method for the simultaneous identification of human active and active-site alkylated DNA repair enzyme, O6-methylguanine-DNA methyltransferase, and its application for monitoring human exposure to alkylating carcinogens. Cancer Res. 54:3726–3731.
   PubMedGoogle Scholar
• Bartek, J., R. Iggo, J. Gannon, and D. P. Lane. 1990. Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines. Oncogene 6:893–899.
   Google Scholar
• Beral, V., E. Banks, G. Reeves, and P. Appleby. 1999. Use of HRT and the subsequent risk of cancer. J. Epidemiol. Biostat. 4:191–210.
   PubMedGoogle Scholar
• Chehab, N. H., A. Malikzay, M. Appel, and T. D. Halazonetis. 2000. Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53. Genes Dev. 14:278–288.
   PubMed Web of Science ®Google Scholar
• Daniels, D. S., C. D. Mol, A. S. Arvai, S. Kanugula, A. E. Pegg, and J. A. Tainer. 2000. Active and alkylated human AGT structures: a novel zinc site, inhibitor and extrahelical base binding. EMBO J. 19:1719–1730.
   PubMed Web of Science ®Google Scholar
• Darnell, J. E.. 1997. STATs and gene regulation. Science 277:1630–1635.
   PubMed Web of Science ®Google Scholar
• Dhingra, K.. 1999. Antiestrogens-tamoxifen, SERMs and beyond. Investig. New Drugs 17:285–311.
   PubMed Web of Science ®Google Scholar
• Dumenco, L. L., E. Allay, K. Norton, and S. L. Gerson. 1993. The prevention of thymic lymphomas in transgenic mice by human O6-alkylguanine-DNA alkyltransferase. Science 259:219–222.
   PubMed Web of Science ®Google Scholar
• El-Deiry, W. S.. 1998. Regulation of p53 downstream genes. Semin. Cancer Biol. 8:345–357.
   PubMed Web of Science ®Google Scholar
• Gerchman, L. L., and D. B. Ludlum. 1973. The properties of O6-methylguanine in template for RNA polymerase. Biochim. Biophys. Acta 308:310–316.
   PubMed Web of Science ®Google Scholar
• Heery, D. M., E. Kalkhoven, S. Hoare, and M. G. Parker. 1997. A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 387:733–736.
   PubMed Web of Science ®Google Scholar
• Hirao, A., Y. Y. Kong, S. Matsuoka, A. Wakeham, J. Ruland, H. Yoshida, D. Liu, S. J. Elledge, and T. W. Mak. 2000. DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science 287:1824–1827.
   PubMed Web of Science ®Google Scholar
• Kastan, M. B., Q. Zhan, W. S. el-Deiry, F. Carrier, T. Jacks, W. V. Walsh, B. S. Plunkett, B. Vogelstein, and A. J. Fornace Jr.. 1992. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71:587–597.
   PubMed Web of Science ®Google Scholar
• Korach, K. S.. 1994. Insights from the study of animals lacking functional estrogen receptor. Science 266:1524–1527.
   PubMedGoogle Scholar
• Kouzarides, T.. 1999. Histone acetylases and deacetylases in cell proliferation. Curr. Opin. Genet. Dev. 9:40–48.
   PubMed Web of Science ®Google Scholar
• Liem, L. K., C. W. Wong, A. Lim, and B. F. L. Li. 1993. Factors influencing the repair of the mutagenic lesion O6-methylguanine in DNA by human O6-methylguanine-DNA methyltransferase. J. Mol. Biol. 231:950–959.
   PubMedGoogle Scholar
• Lim, A., and B. F. L. Li. 1996. The nuclear targeting and nuclear retention properties of a human DNA repair protein MGMT are both required for its nuclear localization: the possible implications. EMBO J. 15:4050–4060.
   PubMedGoogle Scholar
• Loveless, A.. 1969. Possible relevance of O6-alkylation of deoxyguanosine to the mutagenicity and carcinogenicity of nitrosamines and nitrosamides. Nature 223:206–207.
   PubMed Web of Science ®Google Scholar
• Mass, R. A., P. F. Bruning, B. Top, A. J. Breedijk, and H. L. Peterse. 1995. Growth arrest associated changes of mRNA levels in breast cancer cells measured by semi-quantitative RT-PCR: potential early indicators of treatment response. Cancer Lett. 97:107–116.
   PubMedGoogle Scholar
• Mellon, I., G. Spivak, and P. C. Hanawalt. 1987. Selective removal of transcription-blocking DNA damage from the transcribed strand of the mammalian DHFR gene. Cell 51:241–249.
   PubMed Web of Science ®Google Scholar
• Naar, A. M., J. M. Boutin, S. M. Lipkin, V. C. Yu, J. M. Holloway, C. K. Glass, and M. G. Rosenfeld. 1991. The orientation and spacing of core DNA-binding motifs dictate selective transcriptional responses to three nuclear receptors. Cell 65:1267–1279.
   PubMed Web of Science ®Google Scholar
• Nan, X., H. H. Ng, C. A. Johnson, C. D. Laherty, B. M. Turner, R. N. Eisenman, and A. Bird. 1998. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393:386–389.
   PubMed Web of Science ®Google Scholar
• Nolte, R. T., G. B. Wisely, S. Westin, J. E. Cobb, M. H. Lambert, R. Kurokawa, M. G. Rosenfeld, T. M. Willson, C. K. Glass, and M. V. Milburn. 1998. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma. Nature 395:137–143.
   PubMed Web of Science ®Google Scholar
• Oh, H. K., A. K. C. Teo, R. B. Ali, A. Lim, T. C. Ayi, D. B. Yarosh, and B. F. L. Li. 1996. Conformational change in human DNA repair enzyme O6-methylguanine-DNA methyltransferase upon alkylation of its active site by DNA damage-related SN1 and direct-acting SN2 alkylating agents: breaking a “salt-link”?. Biochemistry 35:12259–12266.
   PubMedGoogle Scholar
• Onate, S. A., S. Y. Tsai, M. J. Tsai, and B. W. O'Malley. 1995. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270:1354–1357.
   PubMed Web of Science ®Google Scholar
• Pegg, A. E.. 1990. Mammalian O6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogens and therapeutic agents. Cancer Res. 50:6119–6129.
   PubMed Web of Science ®Google Scholar
• Pegg, A. E.. 2000. Repair of O6-alkylguanine by alkyltransferases. Mutat. Res. 462:83–100.
   PubMed Web of Science ®Google Scholar
• Perera, F. P., and I. B. Weinstein. 2000. Molecular epidemiology: recent advances and future directions. Carcinogenesis 21:517–524.
   PubMed Web of Science ®Google Scholar
• Prall, O. W. J., E. M. Rogan, and R. L. Sutherland. 1998. Estrogen regulation of cell cycle progression in breast cancer cells. J. Steroid Biochem. Mol. Biol. 65:169–174.
   PubMed Web of Science ®Google Scholar
• Ross, R. K., A. Paganini-Hill, P. C. Wan, and M. C. Pike. 2000. Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J. Natl. Cancer Inst. 92:328–332.
   PubMed Web of Science ®Google Scholar
• Selby, C. P., and A. Sancar. 1993. Molecular mechanism of transcription-repair coupling. Science 260:53–58.
   PubMed Web of Science ®Google Scholar
• Shiau, A. K., D. Barstad, P. M. Loria, L. Cheng, P. J. Kushner, D. A. Agard, and G. L. Greene. 1998. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 95:927–937.
   PubMed Web of Science ®Google Scholar
• Shieh, S. Y., J. Ahn, K. Tamai, Y. Taya, and C. Prives. 2000. The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. Genes Dev. 14:289–300.
   PubMed Web of Science ®Google Scholar
• Smigel, K.. 1998. Breast cancer prevention trial shows major benefit, some risk. J. Natl. Cancer Inst. 90:647–648.
   PubMedGoogle Scholar
• Sutherland, R. L., R. E. Hall, and I. W. Taylor. 1983. Cell proliferation kinetics of MCF-7 human mammary carcinoma cells in culture and effects of tamoxifen on exponentially growing and plateau-phase cells. Cancer Res. 43:3998–4006.
   PubMed Web of Science ®Google Scholar
• Teo, I., B. Sedgwick, B. Demple, B. Li, and T. Lindahl. 1984. Induction of resistance to alkylating agents in E. coli: the ada+ gene product serves both as a regulatory protein and as an enzyme for repair of mutagenic damage. EMBO J. 9:2151–2157.
   Google Scholar
• Teo, I., B. Sedgwick, M. W. Kilpatrick, T. V. McCarthy, and T. Lindahl. 1986. The intracellular signal for induction of resistance to alkylating agents in E. coli. Cell 45:315–324.
   PubMed Web of Science ®Google Scholar
• Torchia, J., C. Glass, and M. G. Rosenfeld. 1998. Co-activators and co-repressors in the integration of transcriptional responses. Curr. Opin. Cell Biol. 10:373–383.
   PubMed Web of Science ®Google Scholar
• Utley, R. T., K. Ikeda, P. A. Grant, J. Cote, D. J. Steger, A. Eberharter, S. John, and J. L. Workman. 1998. Transcriptional activators direct histone acetyltransferase complexes to nucleosomes. Nature 394:498–502.
   PubMed Web of Science ®Google Scholar
• Viswanathan, A., H. J. You, and P. W. Doetsch. 1999. Phenotypic change caused by transcriptional bypass of uracil in nondividing cells. Science 284:159–162.
   PubMed Web of Science ®Google Scholar
• Wadgaonkar, R., K. M. Phelps, Z. Haque, A. J. Williams, E. S. Silverman, and T. Collins. 1999. CREB-binding protein is a nuclear integrator of nuclear factor-kappaB and p53 signaling. J. Biol. Chem. 274:1879–1882.
   PubMed Web of Science ®Google Scholar
• Wood, R. D., M. Mitchell, J. Sgouros, and T. Lindahl. 2001. Human DNA repair genes. Science 291:1284–1289.
   PubMed Web of Science ®Google Scholar
• Xu, L., C. K. Glass, and M. G. Rosenfeld. 1999. Coactivator and corepressor complexes in nuclear receptor function. Curr. Opin. Genet. Dev. 9:140–147.
   PubMed Web of Science ®Google Scholar